Tim Draper leads $6m Series A fund raise by wellness tracker Vivoo

Proceeds to support expansion into the soon-to-be $236 billion wellness solutions market

Proceeds to support expansion into the soon-to-be $236 billion wellness solutions market.


A Staff Reporter

Published: Tue 2 Nov 2021, 11:04 PM

Last updated: Tue 2 Nov 2021, 11:06 PM

Vivoo, the first wellness tracker to provide personalised nutrition and lifestyle advice based on at-home urine tests, announces a $6 million Series A fundraise.

The round was led by Draper Associates, with participation from ONCE Ventures, Revo Capital, 500 Startups, Global Ventures, and Halogen Ventures — who specifically invest in technology start-ups led by women.

Proceeds will be used primarily to support the expansion of the team to leverage growing demand for wellness solutions, with the mobile health app market expected to be worth $236 billion by 2026.

Tim Draper, founder and managing director of Draper Associates, said: “Personalised data driven health care is a major theme for us at Draper Associates. Miray and her team at Vivoo are collecting personalised data frictionlessly through a simple at-home pee test with actionable advice that allows customers to be proactive about their health. Wellness has become such a priority over the past year, with more people take proactive control of their health. We’re excited to work with Vivoo as the company expands its footprint globally.”

Launched in 2020, Vivoo already has over 50,000 users from over 100 different countries. Revenue is expected to grow more than 10X in 2021. Vivoo recently forged e-commerce relationships with Amazon and Walmart, increasing its reach exponentially.

Vivoo provides support and customized health advice, within minutes, from weekly at-home urine tests using AI technology. Urine was chosen as the test base as it can gauge thousands of health metrics and is easy to collect. Customers are sent the home testing kits and photograph the urine test strip which is then processed in the Vivoo app.

Users can access data on 15 health factors, including hydration, pH balance, ketones, calcium, magnesium, Vitamin C, free radicals, kidney function, liver function, UTI risk, activity levels, stress levels, menstruation, and overall wellness.

The company continues to invest 20 per cent of its budget in R&D and is expected to announce a significant expansion of its platform in November 2021. The new premium tier will collect three times as much data as before from Vivoo’s proprietary urine test strip technology and integrate with wearable data contained in users’ Apple Health and Google Fit apps.

Miray Tayfun, co-founder and CEO of Vivoo, said: “Like many people interested in health and wellness, we wanted to find a fast, accurate at-home wellness tracker. We tried every health and wellness tracker and at-home test in the market but couldn’t find any single test that provided what we wanted. As bioengineers, we knew there had to be a way to create a simple at-home test and combine it with a recommendation engine to help people learn what their bodies need. With the investment, we will be able to continue to expand and meet the growing demand for customized wellness advice.” — sandhya@khaleejtimes.com

More news from